Newpace

Subcutaneous Implantable Cardioverter Defibrillator

Startup

Newpace is a Caesarea-based startup in the Health Tech & Life Sciences sector, established in 2012. Subcutaneous Implantable Cardioverter Defibrillator. The company has raised a total of $2M across 2 funding rounds, currently at the Seed stage. Newpace was founded by Avi Broder. Key investors include Net Capital Ventures, BioStar Capital. The company has 1-10 employees. Core technologies: Communications, Bluetooth, Materials & Substances, Implants.

With $2M in total funding, Newpace is a Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B/B2B2C business model. Product stage: Clinical Trial. The company holds 1 patent.

$2M
Raised
2
Rounds
2
Investors
3
Team
2012
Founded
1
Patents
Sector & Technology
Health Tech & Life SciencesMedical DevicesLife SupportCommunicationsBluetoothMaterials & SubstancesImplants
At a Glance
Investors
Founders
In the News

3 articles covered by sources including www.prnewswire.com, cardiacrhythmnews.com, www.dicardiology.com.

www.prnewswire.com · Jun 28, 2021
NewPace Selects Wireless Power Market Leader Powermat Technologies to Develop Advanced Wireless Charging Technology for Innovative Life-Saving Devices
Read article ↗
Frequently Asked Questions
What does Newpace do?

NewPace develops a flexible and subcutaneous implantable cardioverter defibrillator (ICD) with no leads within the heart with a wireless rechargeable battery and Bluetooth communication. The NewPace defibrillator differs from standard ICDs in that it does not have leads in the heart. The rechargeable device is implanted subcutaneously with no need for fluoroscopy and communicates via Bluetooth with a smartphone. The string-shaped defibrillator requires one hour per year for wireless recharge and communicates at low energy with smartphones for monitoring. The subcutaneous implantation requires no in-patient care. NewPace partners with China-based Haisco Pharmaceutical.

How much funding has Newpace raised?

Newpace has raised $2M in total funding across 2 rounds. The company is currently at the Seed stage. Key investors include Net Capital Ventures, BioStar Capital.

Who founded Newpace?

Newpace was founded in 2012 by Avi Broder (Co-founder, CFO & VP BD).

What sector is Newpace in?

Newpace operates in Health Tech & Life Sciences, Medical Devices, Life Support, with core technologies in Communications, Bluetooth, Materials & Substances, Implants. Target customers: Healthcare & Life Sciences, Healthcare, Patients, Providers.

Where is Newpace located?

Newpace is based in Granit Street 13, Caesarea, Israel, Center District.

View Full Profile Classic View Website ↗